Picture of Turk Ilac ve Serum Sanayi AS logo

TRILC.E — Turk Ilac ve Serum Sanayi AS Cashflow Statement

0.000.00%
tr flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapContrarian

Annual cashflow statement for Turk Ilac ve Serum Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

2021
December 31st
R2022
December 31st
R2023
December 31st
R2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line37.1-81.715394.7-623
Depreciation
Non-Cash Items10.11671216352,053
Unusual Items
Other Non-Cash Items
Changes in Working Capital-12748.594.6-1,289-878
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-71.7148408-490614
Capital Expenditures-20.6-38.4-115-199-256
Purchase of Fixed Assets
Other Investing Cash Flow Items0.77——-10.1108
Acquisition of Business
Sale of Fixed Assets
Purchase of Investments
Cash from Investing Activities-19.8-38.4-115-209-148
Financing Cash Flow Items-27-148-228-698-1,567
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities136-170-372702-459
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash44.4-60.6-79.1-1.524.8